Post-Antibiotic Era: Non-Drug Alternatives Emerge for Livestock Disease Management, Including Gene Editing and Phage Therapy
Background
Antibiotics, once hailed as powerful weapons, have become a double-edged sword, threatening human health. The rise of antimicrobial resistance (AMR) in bacteria, viruses, and fungi has rendered existing treatments ineffective, posing a global health crisis. In livestock farming, the overuse of antibiotics for productivity enhancement and disease prevention exacerbates the problem. This misuse promotes the development of resistant bacteria, which can spread through the food chain or environment, ultimately infecting humans. Projections indicate that if this trend continues, AMR will cause 10 million deaths annually worldwide by 2050. Deteriorating livestock health and increased mortality rates threaten food security. Reliance on conventional chemical antibiotics is no longer sustainable. Consequently, researchers and industry are striving to develop non-drug therapeutic alternatives to combat pathogens.
Key Findings
Non-drug control technologies, particularly genetic engineering, are at the forefront. CRISPR-Cas systems, a third-generation gene-editing tool, precisely targets and eliminates resistance genes in pathogens. It disrupts the genetic structure of harmful bacteria, preventing their survival and replication. Phage therapy, which selectively targets and kills specific bacteria, is also gaining prominence. Phages bind to bacterial cell walls and inject their genetic material, lysing the host cell. Unlike broad-spectrum antibiotics, phage therapy preserves beneficial gut bacteria while selectively eliminating pathogens. Probiotics and fecal microbiota transplantation (FMT) are proposed to restore microbial ecosystem balance and treat diseases. FMT involves transferring the gut microbial community from healthy individuals to other animals, establishing an immune barrier and preventing the colonization of harmful bacteria. Antimicrobial peptides (AMPs), derived from living organisms, destroy pathogen cell membranes. AMPs are considered promising alternatives to conventional antibiotics due to their lower potential for resistance development. Other potential solutions include phytotherapy using plant extracts and essential oils, nanotechnology for targeted drug delivery, biofilm disruptors that break down bacterial protective layers, and acidifiers that acidify the gut environment to inhibit the growth of harmful bacteria. Vaccination strategies and precision livestock farming (PLF) systems, which integrate information and communication technologies, are also key alternatives. PLF uses real-time sensors to monitor animal behavior and body temperature, detecting early signs of disease. This allows for early isolation or targeted treatment, preventing widespread outbreaks and reducing antibiotic use.
Significance and Outlook
The immediate implementation of these non-drug alternatives faces several challenges. There is a lack of sufficient basic research to demonstrate the safety and efficacy of gene-edited livestock and phage therapy. Addressing knowledge gaps and establishing rigorous biosafety standards and complex regulatory procedures are crucial for accelerating commercialization. Economic barriers also exist. Implementing precision livestock farming equipment or producing customized phage therapies requires significant initial investment and ongoing costs, which may be prohibitive for small-scale farmers. Government funding and infrastructure support are essential. Given the rapid global spread of resistant bacteria, international cooperation and harmonized regulatory standards are urgently needed. Recognizing the interconnectedness of human and animal health, integrated approaches are being actively pursued. Effective AMR management requires a One Health perspective that encompasses the environment, livestock, and humans. The development of non-drug therapies is not only about preserving livestock productivity but also about preventing a major public health disaster.
BACKGROUND: Antimicrobial resistance (AMR) represents an escalating global public health crisis, projected to cause 10 million deaths annually by 2050. Pathogens such as bacteria, viruses, fungi, and parasites evade treatments in animals and humans due to overuse and misuse of antimicrobials, particularly antibiotics, in medical and veterinary practices. This drives a worldwide surge in resistant infections, disproportionately burdening livestock health and productivity. OBJECTIVES: This review examines the global rise of AMR and its impacts on livestock and public health, underscoring the need for non-drug therapeutic alternatives. CONCLUSION: Promising alternatives include genetic engineering and CRISPR-Cas systems, phage therapy, probiotics, antimicrobial peptides, fecal microbiota transplantation, phytotherapy and essential oils, immunomodulators, nanotechnology, biofilm disruptors, acidifiers, vaccination strategies, and precision livestock farming. These approaches target resistance mechanisms without relying on conventional drugs. Despite challenges like knowledge gaps, regulatory barriers, financial limitations, and policy gaps, stakeholders must prioritize accelerated research, regulatory reforms, investments, and international collaboration. Rapid integration of these technologies into human and veterinary medicine is vital to mitigate AMR's health, economic, and social impacts.
The introduction of non-drug antibiotic alternatives is expected to bring about direct changes in livestock farms and the feed industry. For example, in a pig farm, a scenario could be designed where piglets with chronic diarrhea are treated by mixing phages and acidifiers into their feed. Previously, antibiotics were prescribed for short-term treatment, but now, phage therapy can protect the gut microbiome while selectively inhibiting the causative agent, E. coli. Furthermore, installing real-time monitoring cameras and sound sensors in the pigsty can detect early signs of illness, such as coughing or decreased activity. The farmer can then isolate the affected animals and administer customized plant extract essential oils and immunomodulators. This approach prevents widespread infections and ensures the supply of safe, antibiotic-free meat to consumers. This integrated management minimizes economic losses in livestock farming and creates added value by producing antibiotic-free, environmentally friendly meat.